UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060177
Receipt number R000068753
Scientific Title Survey on communication gap between hemodialysis patients and nurses, and consideration of solutions
Date of disclosure of the study information 2026/01/09
Last modified on 2025/12/18 09:08:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey on communication gap between hemodialysis patients and nurses, and consideration of solutions

Acronym

Survey on communication gap between hemodialysis patients and nurses, and consideration of solutions

Scientific Title

Survey on communication gap between hemodialysis patients and nurses, and consideration of solutions

Scientific Title:Acronym

Survey on communication gap between hemodialysis patients and nurses, and consideration of solutions

Region

Japan


Condition

Condition

End-stage kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

By clarifying the communication gaps between hemodialysis patients and nurses and considering countermeasures, we aim to contribute to the improvement of treatment satisfaction and quality of life (QOL) for dialysis patients.

Basic objectives2

Others

Basic objectives -Others

treatment satisfaction
quality of life

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

The current status of communication between hemodialysis patients and nurses (treatment satisfaction and quality of life)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

[Questionnaires]
1.Patients undergoing hemodialysis, aged 18 years old, who have provided informed consent to participate.
2.Nurse survey: Nurses involved in hemodialysis care who have provided informed consent to participate.

[Interviews]
Nurses engaged in dialysis care who have given informed consent.

Key exclusion criteria

N/A

Target sample size

207


Research contact person

Name of lead principal investigator

1st name Shin
Middle name
Last name Tokunaga

Organization

Kyowa Kirin Co., Ltd.

Division name

Medical Affairs

Zip code

100-0004

Address

1-9-2, Otemachi, Chiyoda-ku, Tokyo

TEL

03-5205-7200

Email

hqmarinkensuit.sh@kyowakirin.com


Public contact

Name of contact person

1st name Shin
Middle name
Last name Tokunaga

Organization

Kyowa Kirin Co., Ltd.

Division name

Medical Affairs

Zip code

100-0004

Address

1-9-2, Otemachi, Chiyoda-ku, Tokyo

TEL

03-5205-7200

Homepage URL


Email

hqmarinkensuit.sh@kyowakirin.com


Sponsor or person

Institute

Kyowa Kirin Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Kyowa Kirin Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Review Committee of Kyowa Kirin Co., Ltd.

Address

1-9-2, Otemachi, Chiyoda-ku, Tokyo

Tel

03-5205-7200

Email

researchethics.fj@kyowakirin.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 01 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 12 Month 16 Day

Date of IRB

2025 Year 12 Month 16 Day

Anticipated trial start date

2026 Year 01 Month 09 Day

Last follow-up date

2026 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Multicenter, cross-sectional, non-interventional, study using interviews and questionnaires


Management information

Registered date

2025 Year 12 Month 23 Day

Last modified on

2025 Year 12 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068753